Corline Biomedical AB OMXSTO:CLBIO:
ANNOUNCES DIRECTED SHARE ISSUE RAISING ABOUT 9.24 MSEK
SHARE ISSUE DIRECTED TO CANADIAN COMPANY KARDIUM CORP
TAKES LOAN OF 9.24 MSEK FROM KARDIUM
RECEIVES TOTAL OF ABOUT 18.5 MSEK FROM ISSUE AND LOAN
Corline Flags Share Issue Raising About SEK 9.24 Mln
Earlier from Corline Biomedical Ab
- CLBIO: Breakthrough quarter with FDA approval, long-term deal, and capital raise set stage for growth
- Corline Biomedical Signs 10-Year Agreement With Kardium
- CLBIO: Growth depends on Kardium's US launch, with cost cuts improving results despite lower sales
- CLBIO: Corline's Q1 2025 loss widens, but US market entry and strong clinical data drive optimism